Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
06/2013
06/05/2013CN103130594A Method preparing N-aryl and N-alkyl aromatic amine type compound from phenol type compound
06/04/2013US8455648 1-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3)
06/04/2013US8455647 6-aminoisoquinoline compounds
06/04/2013US8455516 HIV-1 fusion inhibitors and methods
06/04/2013CA2545660C Heterocyclic inhibitors of mek and methods of use thereof
06/04/2013CA2545659C Bicyclic inhibitors of mek
05/2013
05/30/2013US20130137721 6-aminoisoquinoline compounds
05/30/2013US20130137720 Histone demethylase inhibitors and methods for using the same
05/30/2013US20130136794 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
05/29/2013CN103124725A Solid supported gold nanoparticles, methods of use thereof, and methods for making same
05/29/2013CN103121968A Salt of quinoline derivative
05/29/2013CN102206180B Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
05/29/2013CN102060762B Montelukast compound and new preparation method thereof
05/29/2013CN102008459B Antibacterial agents
05/29/2013CN101437785B Method for producing 4-oxoquinoline compound
05/28/2013US8450491 Method for the preparation of montelukast acid and sodium salt thereof in amorphous form
05/28/2013US8450486 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
05/28/2013US8450466 Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
05/28/2013US8450243 Herbicidal quinoline and 1,8-naphthyridine compounds
05/28/2013CA2561897C Thio-substituted biaryl-methanesulfinyl derivatives
05/28/2013CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
05/23/2013WO2013074517A1 Kinase protein binding inhibitors
05/23/2013WO2013072703A1 Antibacterial drug derivatives
05/23/2013WO2013072376A1 Process for the preparation of a quinoline carboxylic acid
05/23/2013WO2013032273A9 Quinolinium single crystals for use in nonlinear optics
05/23/2013US20130131096 8-hydroxy-quinoline derivatives
05/23/2013US20130131036 Novel trpv3 modulators
05/23/2013US20130131021 Analogues of cilostazol
05/23/2013CA2856203A1 Process for the preparation of a quinoline carboxylic acid
05/22/2013EP2593435A1 Synthesis and anticancer activity of aryl and heteroaryl-quinolin derivatives
05/22/2013EP2593432A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
05/22/2013EP2593426A1 1-hydroxyimino-3-phenyl-propanes
05/22/2013EP2592933A1 Mif inhibitors and their uses
05/22/2013CN103119023A Method for manufacturing of quinoline-3-carboxamides
05/22/2013CN103119022A Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof
05/22/2013CN103113298A Preparation method of 7-bromo-4-hydroxy-3-quinoline carboxylic acid
05/22/2013CN103113297A 8-aryl-1-naphthylamide compound and preparation method thereof
05/22/2013CN103113296A Solid-phase chemical preparation method of 8-hydroxyquinoline nickel nanowires
05/22/2013CN103113295A Alkyl-substituted quinolinone compound with side chains as well as preparation method, pharmaceutical composition and application thereof
05/22/2013CN103113294A Synthesizing method of rebamipide
05/22/2013CN103113293A 多取代喹啉衍生物及其制备方法 Poly-substituted quinoline derivatives and a method for preparing
05/22/2013CN103113247A Method for preparing amino-acid ester
05/22/2013CN101479245B Quinolinone derivatives and their pharmaceutical compositions
05/21/2013US8445512 Substituted quinoline-3-carboxamides as KCNQ2/3 modulators
05/21/2013CA2574095C Quinoline derivatives and insecticide comprising thereof as active ingredient
05/21/2013CA2401821C Amino acid derivatives as hiv aspartyl protease inhibitors
05/16/2013WO2013068785A1 Indanone and indandione derivatives and heterocyclic analogs
05/16/2013US20130123344 Method of preventing or treating viral infection
05/16/2013US20130123300 Urea compounds and use thereof for inhibiting apoptosis
05/16/2013US20130123258 4(1H)-Quinolones Having Antimalarial Activity With Reduced Chemical Resistance
05/16/2013US20130123225 Inhibition of bacterial biofilms with aryl carbamates
05/15/2013EP2590949A1 Method for manufacturing of quinoline-3-carboxamides
05/15/2013EP2590948A1 Novel quinoline esters useful for treating skin disorders
05/15/2013CN103102396A Novel thiostrepton analog, amd preparation method and application thereof
05/15/2013CN103102303A Benzylamine derivatives as CETP inhibitors
05/15/2013CN103102302A Quinolinone compound, preparation method and pharmaceutical composition of quinolinone compound and application of pharmaceutical composition
05/15/2013CN102153511B Industrial synthetic method for rubber antioxidant (RD)
05/15/2013CN101808994B Compounds and methods for kinase modulation, and indications therefor
05/14/2013US8440837 2-substituted-ethynylthiazole derivatives and uses of same
05/14/2013US8440831 Process and intermediates for preparing integrase inhibitors
05/14/2013US8440694 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor
05/14/2013US8440693 Substituted isoquinolinones and quinazolinones
05/14/2013US8440691 Tetrahydroquinolinyl compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
05/14/2013US8440595 Fungicides
05/14/2013CA2611889C Substituted tetrahydroquinolines
05/14/2013CA2552463C New compositions containing quinoline compounds
05/14/2013CA2544814C Non-symmetrical gelling agent
05/14/2013CA2535714C Phenoxyacetic acid derivatives
05/10/2013WO2013065059A1 Process for preparation of n,n-di substituted carboxamides
05/10/2013WO2013064465A1 New aryl-quinoline derivatives
05/10/2013WO2013039428A3 Quinoline derivatives and method for producing and using same
05/10/2013WO2013003547A3 Bhq-conjugates, and related compounds, methods of making the same, and methods of use thereof
05/10/2013CA2849945A1 New aryl-quinoline derivatives
05/09/2013US20130116438 Iridium complex and method for producing optically active compound
05/09/2013US20130116437 Process and intermediates for preparing integrase inhibitors
05/09/2013US20130116275 Inhibitors of hif and angiogenesis
05/09/2013US20130116243 Inhibitors of akt activity
05/09/2013US20130116234 Aryl-quinoline derivatives
05/09/2013US20130116206 Quinoline derivatives used as pet imaging agents
05/09/2013US20130115651 Fluorescent dyes
05/08/2013EP2589593A1 (2e)-3-phenyl-n-[2,2,2-trifluoro-1-[[(8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof
05/08/2013EP2589592A1 Novel nicotinamide derivatives or salts thereof
05/08/2013EP2588458A1 Novel tetrahydroquinoline derivatives
05/08/2013EP2588457A1 Pyrazolo-quinolines
05/08/2013EP2588456A1 Novel microbiocidal dioxime ether derivatives
05/08/2013EP2588455A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
05/08/2013EP2588450A1 Napht- 2 -ylacetic acid derivatives to treat aids
05/08/2013CN103097355A Novel quinoline esters useful for treating skin disorders
05/08/2013CN103086958A NF[kappa]B pathway activation inhibitor, preparation method thereof, pharmaceutical composition and purpose
05/08/2013CN102040193B Method for preparing organic micromolecule nano ring and nano tube
05/08/2013CN101827817B Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides
05/08/2013CN101768036B Method for preparing heterocyclic aromatic compound replaced by aryl in alcohol solvent
05/07/2013US8436344 Organic electroluminescent device
05/07/2013US8436242 Photocharge separation using supramolecular complex of π-electron type extended viologen derivative and porphyrin
05/07/2013US8436017 Beta-2-adrenoreceptor agonists
05/07/2013US8436016 Fused heterocyclic M1 receptor positive allosteric modulators
05/07/2013US8436015 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
05/07/2013US8436014 Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
05/02/2013WO2013061074A1 Quinolines as fgfr kinase modulators
05/02/2013US20130109860 Method for manufacturing of quinoline-3-carboxamides
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 277